drugset / Trial / NCT00651703
Safety and Immunogenicity of CYT004-MelQbG10 Vaccine With and Without Adjuvant in Advanced Stage Melanoma Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate a specific cellular immune response in melanoma patients that have been vaccinated with a Melan-A VLP vaccine alone or in combination with different adjuvants.
Timeline
- Start
- 2008-04
- Primary completion
- 2009-12
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CYT004-MelQbG10 | Vaccine | — | Other |
| Subject | Imiquimod | Other / unclassified | — | — |
| Subject | Montanide | Other / unclassified | — | — |